STEPHENS INVESTMENT MANAGEMENT GROUP LLC – Ligand Pharmaceuticals Incorporated Transaction History
STEPHENS INVESTMENT MANAGEMENT GROUP LLC portfolio value:
$38.89M
portfolio value
STEPHENS INVESTMENT MANAGEMENT GROUP LLC quarter portfolio value change:
-3.49%
quarter
Ligand Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.40% | -1.83K shares | -1.56M | $86.11 | 451.73K |
Q2 2022 | share | Increase | +8.60% | 35.90K shares | -6.51M | $89.22 | 453.57K |
Q1 2022 | share | Increase | +1.53% | 6.31K shares | -16.55M | $112.49 | 417.67K |
Q4 2021 | share | Increase | +0.29% | 1.19K shares | 6.39M | $156.16 | 411.35K |
Q3 2021 | share | Increase | +12.87% | 46.77K shares | 9.47M | $139.32 | 410.16K |
Q2 2021 | share | Decrease | -2.00% | -7.41K shares | -8.85M | $131.19 | 363.39K |
Q1 2021 | share | Decrease | -36.32% | -211.48K shares | -1.37M | $152.45 | 370.81K |
Q4 2020 | share | Decrease | -2.07% | -12.31K shares | 1.23M | $99.45 | 582.29K |
Q3 2020 | share | Decrease | -4.70% | -29.30K shares | -13.10M | $95.32 | 594.61K |
Q2 2020 | share | Increase | +7.64% | 44.29K shares | 27.63M | $111.85 | 623.91K |
Q1 2020 | share | Increase | +14.08% | 71.52K shares | -10.84M | $72.72 | 579.62K |
Q4 2019 | share | Decrease | -0.62% | -3.18K shares | 2.09M | $104.29 | 508.1K |
Q3 2019 | share | Increase | +15.63% | 69.09K shares | 417K | $99.54 | 511.28K |
Q2 2019 | share | Increase | +3.89% | 16.54K shares | -3.03M | $114.15 | 442.18K |
Q1 2019 | share | Increase | +4.24% | 17.29K shares | -1.90M | $125.71 | 425.64K |
Q4 2018 | share | Increase | +6.78% | 25.91K shares | -49.56M | $135.7 | 408.34K |
Q3 2018 | share | Decrease | -8.03% | -33.40K shares | 18.48M | $274.49 | 382.43K |
Q2 2018 | share | Decrease | -2.17% | -9.21K shares | 16.28M | $207.17 | 415.84K |
Q1 2018 | share | Decrease | -1.09% | -4.67K shares | 11.36M | $165.16 | 425.05K |
Q4 2017 | share | Decrease | -4.76% | -21.49K shares | -2.59M | $136.93 | 429.73K |
Q3 2017 | share | Increase | +0.66% | 2.95K shares | 7.01M | $136.15 | 451.22K |
Q2 2017 | share | Decrease | -0.04% | -201 shares | 6.95M | $121.4 | 448.27K |
Q1 2017 | share | Increase | +7.98% | 33.14K shares | 5.26M | $105.84 | 448.47K |
Q4 2016 | share | Increase | +6.74% | 26.23K shares | 2.49M | $101.61 | 415.33K |
Q3 2016 | share | Increase | +8.54% | 30.63K shares | -3.04M | $102.06 | 389.1K |
Q2 2016 | share | Decrease | -7.20% | -27.79K shares | 1.39M | $119.27 | 358.47K |
Q1 2016 | share | Decrease | -0.78% | -3.03K shares | -843K | $107.09 | 386.26K |